Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-1991 | 06-1990 | 06-1989 | 06-1988 | 06-1987 | |
| Sales | 3,397,000 | 3,179,000 | 2,570,000 | 2,059,000 | 1,741,000 |
| Operating Expenses | 3,397,000 | 3,179,000 | 2,570,000 | 2,059,000 | 1,741,000 |
| Interest Expense | 75,000 | 44,000 | 26,000 | 21,000 | 11,000 |
| Other Income | 1,358,000 | 1,226,000 | 1,032,000 | 853,000 | 757,000 |
| Pre-tax Income | 1,283,000 | 1,182,000 | 1,006,000 | 832,000 | 746,000 |
| Income Tax | 359,000 | 357,000 | 316,000 | 256,000 | 245,000 |
| Net Income Continuous | 924,000 | 825,000 | 690,000 | 576,000 | 501,000 |
| Net Income Extraordinary | -31,000 | N/A | N/A | 10,000 | 14,000 |
| Minority Interests | -12,000 | -18,000 | -2,000 | -5,000 | -5,000 |
| Net Income | $881,000 | $807,000 | $688,000 | $581,000 | $510,000 |
| EPS Basic Total Ops | 0.37 | 0.34 | 0.58 | 0.49 | 0.43 |
| EPS Basic Continuous Ops | 0.37 | 0.34 | 0.58 | 0.48 | 0.42 |
| EPS Diluted Total Ops | 0.37 | 0.34 | 0.58 | 0.49 | 0.43 |
| EPS Diluted Continuous Ops | 0.37 | 0.34 | 0.58 | 0.48 | 0.42 |
| EBITDA(a) | $1,509,000 | $1,348,000 | $1,125,000 | $926,000 | $812,000 |